These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28238185)

  • 41. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
    Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
    Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor in patients with psoriatic arthritis.
    Fink AM; Cauza E; Hassfeld W; Dunky A; Bayer PM; Jurecka W; Steiner A
    Clin Exp Rheumatol; 2007; 25(2):305-8. PubMed ID: 17543159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced number of circulating endothelial progenitor cells (CD133+/KDR+) in patients with plaque psoriasis.
    Batycka-Baran A; Paprocka M; Krawczenko A; Kantor A; Duś D; Szepietowski JC
    Dermatology; 2012; 225(1):88-92. PubMed ID: 22986416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
    Seker MM; Sancaktar E; Acibucu DO; Filiz AK; Deveci K; Bahceci A; Kacan T; Babacan N; Yuce S
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2929-32. PubMed ID: 24254563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
    Wieczór R; Gadomska G; Góralczyk B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
    Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
    He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
    Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
    Choudhury A; Freestone B; Patel J; Lip GY
    Chest; 2007 Dec; 132(6):1913-9. PubMed ID: 18079224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
    Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
    Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.
    Canavese M; Altruda F; Silengo L; Castiglioni V; Scanziani E; Radaelli E
    Histol Histopathol; 2011 Mar; 26(3):285-96. PubMed ID: 21210341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction.
    Clavel G; Bessis N; Lemeiter D; Fardellone P; Mejjad O; Ménard JF; Pouplin S; Boumier P; Vittecoq O; Le Loët X; Boissier MC
    Clin Immunol; 2007 Aug; 124(2):158-64. PubMed ID: 17560831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SCUBE1: a promising biomarker in renal cell cancer.
    Karagüzel E; Menteşe A; Kazaz İO; Demir S; Örem A; Okatan AE; Altay DU; Yaman SÖ
    Int Braz J Urol; 2017; 43(4):638-643. PubMed ID: 28379666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between severity of the disease and circulating nucleosomes in psoriasis patients.
    Dilek AR; Dilek N; Saral Y; Yüksel D
    Arch Dermatol Res; 2013 Aug; 305(6):483-7. PubMed ID: 23567920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and cyclooxygenase-2 expression in psoriasis.
    Yalçin B; Tezel GG; Arda N; Erman M; Alli N
    Anal Quant Cytol Histol; 2007 Dec; 29(6):358-64. PubMed ID: 18225391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
    Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations.
    Moneib HA; Salem SA; Aly DG; Khedr HT; Wafaey HA; Hassan HE
    J Dermatol; 2012 Jan; 39(1):52-7. PubMed ID: 21950586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
    Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
    Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of plasma signal peptide-Cub-Egf domain-containing protein-1 (SCUBE-1) in an experimental model of acute ischemic stroke.
    Turkmen S; Eryigit U; Karaca Y; Mentese A; Sumer UA; Yulug E; Aksut N; Gazioglu S; Gunduz A
    Am J Emerg Med; 2015 Feb; 33(2):262-5. PubMed ID: 25541225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.